We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01006005
First Posted: November 2, 2009
Last Update Posted: November 22, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of California, San Francisco
October 30, 2009
November 2, 2009
November 22, 2012
July 2007
June 2008   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01006005 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens
Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens
The study is recruiting 50 patients initiating or switching to Atripla and comparing them to 250 individuals previously followed in a prospective study of HIV+ low income individuals recruited from homeless shelters, single room occupancy hotels and free meal food lines as part of the UCSF Reach Study. Adherence will be measured through monthly unannounced pill counts and electronic medication monitors.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
HIV infected, marginally housed
  • HIV Infections
  • Adherence
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
51
June 2008
June 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18+ years old;
  • HIV+;
  • Initiating Atripla within 6-months of recruitment;
  • Lives in the Tenderloin, South of Market, or Mission District San Francisco;
  • Capable of providing informed consent; and
  • Willing to complete all study procedures.

Exclusion Criteria:

  • Intoxication, cognitive dysfunction or psychosis will preclude potential subjects from informed consent.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01006005
IN-US-177-0106
No
Not Provided
Not Provided
University of California, San Francisco
University of California, San Francisco
Not Provided
Not Provided
University of California, San Francisco
November 2012